Serum interleukin‐15 is elevated in systemic lupus erythematosus

Objective. To investigate if interleukin‐15 (IL‐15) (rather than IL‐2) is increased in systemic lupus erythematosus (SLE) and might be responsible for immunological abnormalities of SLE such as the increased lymphocytic expression of Bcl‐2 and CD25. Methods. Serum IL‐15, IL‐2 and tumour necrosis fac...

Full description

Saved in:
Bibliographic Details
Published in:Rheumatology (Oxford, England) England), 2001-08, Vol.40 (8), p.876-881
Main Authors: Aringer, M., Stummvoll, G. H., Steiner, G., Köller, M., Steiner, C. W., Höfler, E., Hiesberger, H., Smolen, J. S., Graninger, W. B.
Format: Article
Language:English
Subjects:
Adult
Arthritis, Rheumatoid - immunology
Bcl‐2
Biological and medical sciences
CD25
ELISA
Female
Humans
IL‐15
IL‐15R
IL‐2
Interleukin-15 - blood
Lupus Erythematosus, Systemic - immunology
Lymphocyte
Lymphocyte Activation
Male
Medical sciences
Middle Aged
Proto-Oncogene Proteins c-bcl-2 - analysis
Receptors, Interleukin-2 - analysis
Sarcoidosis. Granulomatous diseases of unproved etiology. Connective tissue diseases. Elastic tissue diseases. Vasculitis
SLE
TNF
Tumor Necrosis Factor-alpha - analysis
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective. To investigate if interleukin‐15 (IL‐15) (rather than IL‐2) is increased in systemic lupus erythematosus (SLE) and might be responsible for immunological abnormalities of SLE such as the increased lymphocytic expression of Bcl‐2 and CD25. Methods. Serum IL‐15, IL‐2 and tumour necrosis factor (TNF) levels of 65 SLE patients, 20 healthy persons and 10 rheumatoid arthritis (RA) patients were measured by enzyme‐linked immunosorbent assay (ELISA). For 25 SLE patients, the percentage of CD25 + lymphocytes and the lymphocytic Bcl‐2 levels were simultaneously determined by fluorocytometry. Peripheral blood mononuclear cells (PBMC) of 15 SLE patients were incubated with or without recombinant IL‐15 and the influence on Bcl‐2 and CD25 was determined. Results. IL‐15 was found to be elevated in 25 SLE sera (38%), but in none of the 20 healthy sera (P = 0.0005) and none of the 10 RA sera. Both lymphocyte CD25 and Bcl‐2 expression significantly correlated with serum IL‐15 and were increased by recombinant IL‐15. Conclusion. Serum IL‐15 may in part be responsible for the immunological abnormalities seen in active SLE.
ISSN:1462-0324
1462-0332
DOI:10.1093/rheumatology/40.8.876